S'abonner

Clinical performance of early warning scoring systems for identifying sepsis among anti-hypertensive agent users - 09/10/21

Doi : 10.1016/j.ajem.2021.03.091 
Itsuki Osawa, MD a, , Tomohiro Sonoo, MD b, c, Shoko Soeno, MD d, Konan Hara, MD, PhD c, e, Kensuke Nakamura, MD, PhD b, Tadahiro Goto, MD, MPH, PhD c, f
a Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, Tokyo, Japan 
b Department of Emergency and Critical Care Medicine, Hitachi General Hospital, Ibaraki, Japan 
c TXP Medical Co. Ltd., Tokyo, Japan 
d Department of Emergency Medicine, Southern Tohoku General Hospital, Fukushima, Japan 
e Department of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 
f Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan 

Corresponding author at: Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo 1138655, Japan.Department of Emergency and Critical Care MedicineThe University of Tokyo Hospital7-3-1, HongoBunkyo-kuTokyo1138655Japan

Abstract

Background

Little is known about the accuracy of the quick Sequential Organ Failure Assessment (qSOFA) and the National Early Warning Score (NEWS) in identifying sepsis patients with a history of hypertension on anti-hypertensive agents, which affect vital signs as components of the scoring systems. We aimed to examine the ability of qSOFA and NEWS to predict sepsis among anti-hypertensive agent users by comparing them with non-users.

Methods

We retrospectively identified adult patients (aged ≥18years) with suspected infection who presented to an emergency department (ED) of a large tertiary medical center in Japan between April 2018 and March 2020. Suspected infection was defined based on the chief complaint of fever, high body temperature, or the clinical context on arrival at the ED. We excluded patients who had trauma or cardiac arrest, those who were transported to other hospitals after arrival at the ED, and those whose vital signs data were mostly missing. The predictive performances of qSOFA and NEWS based on initial vital signs were examined separately for sepsis, ICU admission, and in-hospital mortality and compared between anti-hypertensive agent users and non-users.

Results

Among 2900 patients with suspected infection presenting to the ED, 291 (10%) had sepsis, 1023 (35%) were admitted to the ICU, and 188 (6.5%) died. The prediction performances of qSOFA and NEWS for each outcome among anti-hypertensive agent users were lower than that among non-users (e.g., c-statistics of qSOFA for sepsis, 0.66 vs. 0.71, p = 0.07; and for ICU admission, 0.70 vs. 0.75, p = 0.01). For identifying sepsis, the sensitivity and specificity of qSOFA ≥2 were 0.43 and 0.77 in anti-hypertensive agent users and 0.51 and 0.82 in non-users. Similar associations were observed for identifying ICU admission and in-hospital mortality. Regardless of the use of anti-hypertensive agents, NEWS had better prediction abilities for each outcome than qSOFA.

Conclusion

The clinical performance of qSOFA and NEWS for identifying sepsis among anti-hypertensive agent users was likely lower than that among non-users.

Le texte complet de cet article est disponible en PDF.

Keywords : qSOFA, NEWS, Sepsis, Anti-hypertensive agent, Emergency department


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 48

P. 120-127 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • The impact of the COVID-19 pandemic and governor mandated stay at home order on emergency department super utilizers
  • Shannon Alwood, Mandi W. Musso, Glenn N. Jones, Joel Mosley, Brittany Wippel, Lauren Theriot, Diana Hamer
| Article suivant Article suivant
  • On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study
  • Seung Mi Oh, John P. Skendelas, Eric Macdonald, Michael Bergamini, Swati Goel, Jaeun Choi, Kathryn R. Segal, Kumar Vivek, Singh Nair, Jonathan Leff

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.